CT-721 is primarily used in the field of medical research, particularly in the development of therapeutic agents targeting specific diseases. Its application is significant in the study of cancer therapies, where it is investigated for its potential to inhibit certain pathways involved in tumor growth and progression. Researchers are exploring its efficacy in enhancing the effectiveness of existing treatments or as a standalone therapy. Additionally, CT-721 is being studied for its role in modulating immune responses, which could lead to advancements in immunotherapy for various conditions. Its precise mechanism and broader applications continue to be a focus of ongoing scientific inquiry.